IRMD (iRadimed Corporation)
Insider Trading Activity
Every open-market purchase and sale reported by IRMD officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-08 | MONTY K ALLEN | Director | Sell | — | — |
| 2026-06-23 | JOHN GLENN | CFO | MIXED | — | — |
| 2026-06-04 | Hilda Frederique Scharen-Guivel | Director | Sell | — | — |
| 2026-06-02 | Roger E. Susi | CEO, President, Chairman | Sell | — | — |
| 2026-05-28 | Roger E. Susi | CEO, President, Chairman | Sell | — | — |
| 2026-05-20 | Roger E. Susi | CEO, President, Chairman | Sell | — | — |
| 2026-05-13 | Roger E. Susi | CEO, President, Chairman | Sell | — | — |
| 2026-05-06 | Roger E. Susi | CEO, President, Chairman | Sell | — | — |
| 2026-04-22 | Roger E. Susi | CEO, President, Chairman | Sell | — | — |
| 2026-04-15 | Roger E. Susi | CEO, President, Chairman | Sell | — | — |
| 2026-04-07 | Roger E. Susi | CEO, President, Chairman | Sell | — | — |
| 2026-04-01 | Roger E. Susi | CEO, President, Chairman | Sell | — | — |
| 2026-03-25 | Roger E. Susi | CEO, PRESIDENT, CHAIRMAN | Sell | — | — |
| 2026-03-18 | Roger E. Susi | CEO, PRESIDENT, CHAIRMAN | Sell | — | — |
| 2026-03-10 | Roger E. Susi | CEO, PRESIDENT, CHAIRMAN | Sell | — | — |
| 2026-03-09 | Roger E. Susi | CEO, PRESIDENT, CHAIRMAN | Sell | — | — |
| 2026-03-05 | Jeff Chiprin | Chief Commercial Officer | A | — | — |
| 2026-03-05 | JOHN GLENN | CHIEF FINANCIAL OFFICER | A | — | — |
| 2026-02-13 | MONTY K ALLEN | Director | Sell | — | — |
| 2026-01-27 | Roger E. Susi | CEO, PRESIDENT, CHAIRMAN | Sell | — | — |
| 2026-01-21 | Roger E. Susi | CEO, PRESIDENT, CHAIRMAN | Sell | — | — |
| 2026-01-13 | Roger E. Susi | CEO, PRESIDENT, CHAIRMAN | Sell | — | — |
| 2026-01-06 | Roger E. Susi | CEO, PRESIDENT, CHAIRMAN | Sell | — | — |
| 2025-12-30 | Roger E. Susi | CEO, PRESIDENT, CHAIRMAN | Sell | — | — |
| 2025-12-22 | Roger E. Susi | CEO, PRESIDENT, CHAIRMAN | Sell | — | — |
| 2025-12-17 | Roger E. Susi | CEO, PRESIDENT, CHAIRMAN | Sell | — | — |
| 2025-12-15 | MONTY K ALLEN | Director | A | — | — |
| 2025-12-15 | JAMES B HAWKINS | Director | A | — | — |
| 2025-12-15 | Hilda Frederique Scharen-Guivel | Director | A | — | — |
| 2025-12-12 | Jeff Chiprin | Chief Commercial Officer | MIXED | — | — |
| 2025-12-12 | JAMES B HAWKINS | Director | M | — | — |
| 2025-12-12 | Hilda Frederique Scharen-Guivel | Director | M | — | — |
| 2025-12-12 | MONTY K ALLEN | Director | M | — | — |
| 2025-12-12 | JOHN GLENN | CHIEF FINANCIAL OFFICER | MIXED | — | — |
| 2025-12-10 | JAMES B HAWKINS | Director | Sell | — | — |
| 2025-12-10 | JOHN GLENN | CHIEF FINANCIAL OFFICER | MIXED | — | — |
| 2025-12-09 | MONTY K ALLEN | Director | M | — | — |
| 2025-12-09 | Hilda Frederique Scharen-Guivel | Director | M | — | — |
| 2025-12-09 | Roger E. Susi | CEO, PRESIDENT, CHAIRMAN | Sell | — | — |
| 2025-12-09 | JAMES B HAWKINS | Director | M | — | — |
| 2025-12-02 | Roger E. Susi | CEO, PRESIDENT, CHAIRMAN | Sell | — | — |
| 2025-11-24 | Roger E. Susi | CEO, PRESIDENT, CHAIRMAN | Sell | — | — |
| 2025-11-21 | JAMES B HAWKINS | Director | Sell | — | — |
| 2025-11-19 | Roger E. Susi | CEO, PRESIDENT, CHAIRMAN | Sell | — | — |
| 2025-11-12 | JOHN GLENN | CHIEF FINANCIAL OFFICER | Sell | — | — |
| 2025-11-12 | Roger E. Susi | CEO, PRESIDENT, CHAIRMAN | Sell | — | — |
| 2025-11-04 | Roger E. Susi | CEO, PRESIDENT, CHAIRMAN | Sell | — | — |
| 2025-10-29 | Roger E. Susi | CEO, PRESIDENT, CHAIRMAN | Sell | — | — |
| 2025-10-22 | Roger E. Susi | CEO, PRESIDENT, CHAIRMAN | Sell | — | — |
| 2025-10-15 | Hilda Frederique Scharen-Guivel | Director | M | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | CEO, President, Chairman | 2,162,500 | — |
| — | Director | 247,546 | — |
| — | Chief Exec Officer & Director | 151,936 | — |
| — | Controller | 54,225 | — |
| — | VP of Reg. and Qual. Assurance | 53,569 | — |
| — | Chief Operating Officer | 43,315 | — |
| — | Director | 29,647 | — |
| — | Director | 19,986 | — |
| — | Director | 19,759 | — |
| — | Director | 15,985 | — |
| — | CFO | 14,256 | — |
| — | CFO & Secretary | 13,710 | — |
| — | Exec. VP of WW Sales and Mktg | 6,940 | — |
| — | Director | 5,598 | — |
| — | Chief Commercial Officer | 687 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the IRMD quote page; the site-wide leaderboard is on the insider transactions hub.